Heart Test Laboratories Inc Common Stock

Yahoo Finance • 12 days ago

HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Southlake, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG... Full story

Yahoo Finance • 4 months ago

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

Southlake, TX, Dec. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advancing the use of ECG/EKGs through the integration of ar... Full story

Yahoo Finance • 7 months ago

HeartSciences Inc (NASDAQ:HSCS) Reports Q1 FY2026 Results with Narrower-Than-Expected Loss and Positive Business Updates

HeartSciences Inc (NASDAQ:HSCS [https://www.chartmill.com/stock/quote/HSCS]) reported its first quarter fiscal 2026 financial results, posting no revenue and a non-GAAP loss per share of $1.58. The company's performance relative to analyst... Full story

Yahoo Finance • 7 months ago

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

Southlake, TX, Sept. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc.(Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier d... Full story

Yahoo Finance • 7 months ago

HeartSciences Announces Conference Participation and Investor Webinar

Southlake, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc.(Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier de... Full story

Yahoo Finance • 8 months ago

Heartsciences' director Hilz sells $15,621 in shares

HeartSciences Inc. (NASDAQ:HSCS) Director Mark T. Hilz, who is also the company’s COO and Secretary, sold 4,416 shares of common stock on July 29, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The micro-ca... Full story

Yahoo Finance • 8 months ago

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

Southlake, TX, July 24, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc.(Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier de... Full story

Yahoo Finance • 9 months ago

HeartSciences amends bylaws to add jury trial waiver and ownership threshold

HeartSciences Inc. (NASDAQ:HSCS) announced that its board of directors adopted amendments to the company’s bylaws on Friday. The changes were made in connection with recent updates to the Texas Business Organizations Code and in accordance... Full story

Yahoo Finance • 10 months ago

Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream

MIAMI, May 21, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Conference on May 21 & 22, 2025. The Emerging Growth Conference identifies compan... Full story

Yahoo Finance • 10 months ago

Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream

MIAMI, May 20, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Conference on May 21 & 22, 2025. The Emerging Growth Conference identifies compan... Full story

Yahoo Finance • 11 months ago

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

Southlake, TX, May 07, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives throu... Full story

Yahoo Finance • 3 years ago

HeartSciences Receives Two New Patent Allowances, Expanding its International Patent Portfolio

Southlake, Texas, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an AI-powered medical technology company focused on transforming ECGs/EKGs t... Full story

Yahoo Finance • 3 years ago

HeartSciences to Participate in the Maxim Group Virtual Tech Conference Series: Emerging Growth in A.I.

Southlake, TX, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based medical technology company focused on tra... Full story

Yahoo Finance • 3 years ago

HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine

Southlake, Texas, May 17, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on tr... Full story

Yahoo Finance • 3 years ago

HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 a.m. Pacific Time

Southlake, Texas, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also k... Full story

Yahoo Finance • 3 years ago

Maxim Group LLC to Host the Healthcare IT Virtual Conference on Wednesday, January 25th at 8:15 A.M. ET 

NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the Healthc... Full story